Boston, MA -- (SBWIRE) -- 12/06/2013 -- Developments this quarter showcase strong relations between Oman and India. As one of the main destinations of medical tourism, India will continue to benefit from Oman's increasingly burdened public healthcare system. Similarly, strong growth prospects in both the pharmaceutical and healthcare industries will provide Indian companies with a healthy return on investment.

Headline Expenditure Projections

- Pharmaceuticals: OMR160mn (US$415mn) in 2012 to OMR175mn (US$461mn) in 2013; 9.7% in local currency terms and +11.1% in US dollar terms. Forecast broadly in line with Q413.
- Healthcare: OMR724mn (US$1.88bn) in 2012 to OMR799mn (US$2.05bn) in 2013; +7.6% in local currency terms and +9.0 in US dollar terms. Forecast broadly in line with Q413.

View Full Report Details and Table of Contents

Risk/Reward Rating

Oman has limited longer-term commercial potential due to its small population and the fact that the government is responsible for the bulk of healthcare costs, which will increase the need for cost containment in the coming years. For Q114, Oman's Pharmaceutical Risk/Reward Rating (RRR) score has dropped by two basis points to 44 out of 100, although maintains its 11th position in the region.

Key Trends And Developments

September 2013

According to travel media estimates released in September, the number of Omanis seeking medical care in foreign countries is expected to reach 75,000 in 2013. The number of Omanis that visited India in 2012 for medical treatment, approximately 3,400, was more than double than that in 2011. Other countries of interest include Germany, the UK, the UAE and Saudi Arabia Moreover, nearly 60,000 Omanis flew to Thailand in 2012 seeking medical care for various conditions. Omanis seek treatment in foreign countries due to long waiting lists for surgical and other procedures at the kingdom's public hospitals.

A number of Indian companies, which formed part of an 18-member delegation to Oman to participate in the MedHealth and Wellness Exhibition, expressed interest in business opportunities in the country in order to benefit from Oman's growing healthcare sector, stated the Muscat Daily. According to Vinod Pal director of the Federation of Indian Export Organisations (FIEO), a number of companies are looking to enter the Oman market and tap into opportunities in the healthcare sector.

BMI Economic View: Oman's near-term economic outlook remains broadly favourable, with non-oil growth to be fuelled over the coming quarters by expansionary public spending policies and healthy domestic demand. We have made slight revisions to our growth forecasts, and now project real GDP to expand by 4.7% in 2013 in real terms, moderating to 3.5% in 2014 (from 4.4% and 3.8% previously).

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Healthcare research reports at Fast Market Research

You may also be interested in these related reports:

- Slovenia Pharmaceuticals & Healthcare Report Q1 2014
- Latvia Pharmaceuticals & Healthcare Report Q1 2014
- Croatia Pharmaceuticals & Healthcare Report Q1 2014
- Netherlands Pharmaceuticals & Healthcare Report Q1 2014
- Australia Pharmaceuticals & Healthcare Report Q1 2014
- Nigeria Pharmaceuticals & Healthcare Report Q1 2014
- Mexico Pharmaceuticals & Healthcare Report Q1 2014
- Central America Pharmaceuticals & Healthcare Report Q1 2014
- Poland Pharmaceuticals & Healthcare Report Q1 2014
- Argentina Pharmaceuticals & Healthcare Report Q1 2014